blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2425252

EP2425252 - IDENTIFICATION OF TUMOR-ASSOCIATED MARKERS FOR DIAGNOSIS AND THERAPY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.01.2014
Database last updated on 12.07.2024
Most recent event   Tooltip03.01.2014Application deemed to be withdrawnpublished on 05.02.2014  [2014/06]
Applicant(s)For all designated states
GANYMED Pharmaceuticals AG
Freiligrathstrasse 12
55131 Mainz / DE
For all designated states
Johannes-Gutenberg-Universität Mainz
Saarstrasse 21
55122 Mainz / DE
[N/P]
Former [2012/10]For all designated states
GANYMED Pharmaceuticals AG
Freiligrathstrasse 12
55131 Mainz / DE
For all designated states
Johannes- Gutenberg-Universität Mainz
Saarstrasse 21
55122 Mainz / DE
Inventor(s)01 / SAHIN, Ugur
Philipp-von-Zabern-Platz 1
55116 Mainz / DE
02 / TÜRECI, Özlem
Philipp-von-Zabern-Platz 1
55116 Mainz / DE
03 / KOSLOWSKI, Michael
Am Ried 23
85764 Oberschleissheim / DE
 [2013/01]
Former [2012/10]01 / SAHIN, Ugur
Philipp-von-Zabern-Platz 1
55116 Mainz / DE
02 / TÜRECI, Özlem
Philipp-von-Zabern-Platz 1
55116 Mainz / DE
03 / KOSLOWSKI, Michael
Autogenstrasse 50
65933 Frankfurt / DE
Representative(s)Schnappauf, Georg
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[N/P]
Former [2012/10]Schnappauf, Georg
Dr. Volker Vossius
Patent- und Rechtsanwaltskanzlei
Geibelstrasse 6
81679 München / DE
Application number, filing date10716294.322.04.2010
WO2010EP02490
Priority number, dateEP2009000593129.04.2009         Original published format: EP 09005931
US20090173871P29.04.2009         Original published format: US 173871 P
[2012/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010124812
Date:04.11.2010
Language:EN
[2010/44]
Type: A2 Application without search report 
No.:EP2425252
Date:07.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.2010 takes the place of the publication of the European patent application.
[2012/10]
Search report(s)International search report - published on:EP21.04.2011
ClassificationIPC:G01N33/574
[2012/10]
CPC:
G01N33/57484 (EP,US); A61K31/7088 (EP,US); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/10]
Extension statesAL11.11.2011
BA11.11.2011
ME11.11.2011
RS11.11.2011
TitleGerman:IDENTIFIZIERUNG TUMORASSOZIIERTER MARKER FÜR DIAGNOSE UND THERAPIE[2012/10]
English:IDENTIFICATION OF TUMOR-ASSOCIATED MARKERS FOR DIAGNOSIS AND THERAPY[2012/10]
French:Identification des marqueurs associés aux tumeurs pour diagnostic et thérapie[2012/10]
Entry into regional phase11.11.2011National basic fee paid 
11.11.2011Designation fee(s) paid 
11.11.2011Examination fee paid 
Examination procedure11.11.2011Amendment by applicant (claims and/or description)
11.11.2011Examination requested  [2012/10]
18.02.2013Despatch of a communication from the examining division (Time limit: M06)
29.08.2013Application deemed to be withdrawn, date of legal effect  [2014/06]
25.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/06]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.02.2013
Fees paidRenewal fee
29.03.2012Renewal fee patent year 03
26.04.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2007042392  (TANG Y T [US], et al) [X] 1,3,4,21,22,24,27,28,32-34 * claims 1,10,16,19-23,27,28; sequences 173, 1157 *;
 [Y]WO2006100089  (GANYMED PHARMACEUTICALS AG [DE], et al) [Y] 1-34 * the whole document *
    [ ] - GENESEQ, (20071004), Database accession no. AGI32203, URL: EBI, XP002547876 [ ] * abstract *
    [ ] - GENESEQ, (20071004), Database accession no. AGI31219, URL: EBI, XP002547942 [ ] * abstract *
 [Y]  - KOSLOWSKI MICHAEL ET AL, "A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US, (20071001), vol. 67, no. 19, ISSN 0008-5472, pages 9528 - 9534, XP002471063 [Y] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-07-1350
by applicant   - PARDOLL, NAT. MED., (1998), vol. 4, pages 525 - 31
    - ADAMS GP; WEINER LM, NAT BIOTECHNOL, (2005), vol. 23, pages 1147 - 57
    - BEARD J, "trophoblastic theory of cancer", LANCET, (1902), vol. 1, pages 1758 - 63
    - GURCHOT C, ONCOLOGY, (1975), vol. 31, pages 310 - 3
    - ACEVEDO HF ET AL., CANCER, (1995), vol. 76, pages 1467 - 75
    - DIRNHOFER S ET AL., HUM PATHOL, (1998), vol. 29, pages 377 - 82
    - ILES RK; CHARD T, J UROL, (1991), vol. 145, pages 453 - 8
    - LAURENCE DJ; NEVILLE AM, BR J CANCER, (1972), vol. 26, pages 335 - 55
    - KOSLOWSKI M ET AL., CANCER RES, (2004), vol. 64, pages 5988 - 93
    - SIMPSON AJ ET AL., NAT REV CANCER, (2005), vol. 5, pages 615 - 25
    - SMITH; WATERMAN, ADS APP. MATH., (1981), vol. 2, page 482
    - NEDDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 443
    - PEARSON; LIPMAN, PROC. NATL ACAD. SCI. USA, (1988), vol. 85, page 2444
    - PHILIP SHEPHERD; CHRISTOPHER DEAN, MONOCLONAL' ANTIBODIES: A PRACTICAL APPROACH
    - AZORSA ET AL., J. IMMUNOL. METHODS, (1999), vol. 229, pages 35 - 48
    - ANDERSON ET AL., J. IMMUNOL., (1989), vol. 143, pages 1899 - 1904
    - GARDSVOLL, J. IMMUNOL. METHODS, (2000), vol. 234, pages 107 - 116
    - PHILIP SHEPHERD; CHRISTOPHER DEAN, MONOCLONAL ANTIBODIES: A PRACTICAL APPROACH
    - PAUL CALABRESI; BRUCE A. CHABNER, ANTINEOPLASTIC AGENTS
    - ALTMAN ET AL., SCIENCE, (1996), vol. 274, pages 94 - 96
    - DUNBAR ET AL., CURR. BIOL., (1998), vol. 8, pages 413 - 416
    - GREENBERG, J IMMUNOL., (1986), vol. 136, no. 5, page 1917
    - RIDDEL ET AL., SCIENCE, (1992), vol. 257, page 238
    - LYNCH ET AL., EUR. J IMMUNOL., (1991), vol. 21, pages 1403 - 1410
    - KAST ET AL., CELL, (1989), vol. 59, pages 603 - 614
    - STANISLAWSKI ET AL., NAT IMMUNOL., (2001), vol. 2, pages 962 - 70
    - KESSELS ET AL., NAT IMMUNOL., (2001), vol. 2, pages 957 - 61
    - OSSENDORP ET AL., IMMUNOL LETT., (2000), vol. 74, pages 75 - 9
    - OSSENDORP ET AL., J EXP. MED., (1998), vol. 187, pages 693 - 702
    - MALOY ET AL., PROC NATL ACAD SCI USA, (2001), vol. 98, pages 3299 - 303
    - SO ET AL., MOL. CELLS, (1997), vol. 7, pages 178 - 186
    - KREIG ET AL., NATURE, (1995), vol. 374, pages 546 - 9
    - SCIENCE, (1995), vol. 268, pages 1432 - 1434
    - CHOMCZYNSKI; SACCHI, ANAL. BIOCHEM., (1987), vol. 162, pages 156 - 159
    - GARDSVOLL, J IMMUNOL. METHODS, (2000), vol. 234, pages 107 - 116
    - KAYYEM ET AL., EUR. J BIOCHEM., (1992), vol. 208, pages 1 - 8
    - SPILLER ET AL., J IMMUNOL. METHODS, (1999), vol. 224, pages 51 - 60
    - PHILLIP SHEPHERD; CHRISTOPHER DEAN, MONOCLONAL ANTIBODIES: A PRACTICAL APPROACH
    - AZORSA ET AL., J IMMUNOL. METHODS, (1999), vol. 229, pages 35 - 48
    - ANDERSON ET AL., J IMMUNOL., (1989), vol. 143, pages 1899 - 1904
    - GARDSVOLL, J IMMUNOL. METHODS., (2000), vol. 234, pages 107 - 116
    - JUNG ET AL., MOL. CELLS, (2001), vol. 12, pages 41 - 49
    - KASINRERK ET AL., HYBRID HYBRIDOMICS, (2002), vol. 21, pages 287 - 293
    - WILDT ET AL., J. IMMUNOL. METHODS, (1997), vol. 207, pages 61 - 67
    - LEMOINE ET AL., METHODS MOL. BIOL., (1997), vol. 75, pages 441 - 7
    - DAVID J.; MD DABBS, DIAGNOSTIC IMMUNOHISTOCHEMISTRY
    - MICROSCOPY, IMMUNOHISTOCHEMISTRY, AND ANTIGEN RETRIEVAL METHODS: FOR LIGHT AND ELECTRON MICROSCOPY
    - SHI ET AL., J HISTOCHEM. CYTOCHEM., (1991), vol. 39, pages 741 - 748
    - SHIN ET AL., LAB. INVEST., (1991), vol. 64, pages 693 - 702
    - DURAND; SETA, CLIN. CHEM., (2000), vol. 46, pages 795 - 805
    - HAKOMORI, CANCER RES., (1996), vol. 56, pages 5309 - 18
    - HANNON, GJ., "RNA interference", NATURE, (2002), vol. 418, pages 244 - 51
    - CZAUDERNA ET AL., NUCL. ACID RES., (2003), vol. 31, pages 670 - 82
    - CINAMON G.; ALON R., J. IMMUNOL. METHODS., (200302), vol. 273, no. 1-2, pages 53 - 62
    - STOCKTON ET AL., MOL. BIOL. CELL, (2001), vol. 12, pages 1937 - 56
    - ABATE-SHEN; SHEN, TRENDS IN GENETICS, (2002), page L-5
    - MATSUSUE ET AL., J. CLIN. INVEST., (2003), vol. 111, pages 737 - 47
    - JEGSTRUP I. ET AL., LAB ANIM., (200301), vol. 37, no. 1, pages 1 - 9
    - ZAMBROWICZ BP; SANDS AT, NAT. REV. DRUG DISCOV., (200301), vol. 2, no. 1, pages 38 - 51
    - NIWA H., CELL STRUCT. FUNCT., (200106), vol. 26, no. 3, pages 137 - 48
    - BALLING R, ANN. REV. GENOMICS HUM. GENET., (2001), vol. 2, pages 463 - 92
    - PETERS T. ET AL., HUM. MOL. GENET, (2003), vol. 12, pages 2109 - 20
    - KOSLOWSKI, M. ET AL., CANCER RES., (2002), vol. 62, pages 6750 - 6755
    - KOSLOWSKI, M. ET AL., CANCER RES., (2004), vol. 64, pages 5988 - 5993
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.